Clinical Trials Browser

Phase 3 × INDUSTRY × Certolizumab Pegol × Clear all

NCT03357471 2019-10-25

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Phase 3 Completed

70 enrolled 16 charts

Lymphoma, Follicular

NCT00552058 2018-08-09

Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

Phase 3 Completed

439 enrolled 25 charts

Crohn Disease

NCT00333788 2018-08-07

Welcome2

Phase 3 Completed

233 enrolled 31 charts

Crohn Disease

NCT00354367 2012-05-28

Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas

Phase 3 Withdrawn

Crohn Disease, Fistula

NCT00358683 2012-05-28

A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease

Phase 3 Withdrawn

Crohn Disease

NCT00297648 2011-08-31

MUSIC

Phase 3 Completed

89 enrolled 43 charts

Crohn Disease